日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma

可溶性PD-1水平升高可预测黑色素瘤患者对纳武利尤单抗联合伊匹木单抗的疗效

Pedersen, Jesper Geert; Sokac, Mateo; Sørensen, Boe Sandahl; Luczak, Adam Andrzej; Aggerholm-Pedersen, Ninna; Birkbak, Nicolai Juul; Øllegaard, Trine Heide; Jakobsen, Martin Roelsgaard

Inflammatory Cytokines and ctDNA Are Biomarkers for Progression in Advanced-Stage Melanoma Patients Receiving Checkpoint Inhibitors

炎症细胞因子和ctDNA是接受免疫检查点抑制剂治疗的晚期黑色素瘤患者疾病进展的生物标志物

Pedersen, Jesper Geert; Madsen, Anne Tranberg; Gammelgaard, Kristine Raaby; Aggerholm-Pedersen, Ninna; Sørensen, Boe Sandahl; Øllegaard, Trine Heide; Jakobsen, Martin Roelsgaard